Evidence map›Paper›PMID 23054079›Full record

ArticleApoptosis : an international journal on programmed cell death2013

In vivo knockdown of intersectin-1s alters endothelial cell phenotype and causes microvascular remodeling in the mouse lungs.

Cristina Bardita, Dan Predescu, Matthew J Justice, Irina Petrache, Sanda Predescu

Open access · hybridAbstract read
In one paragraph

Article in Apoptosis : an international journal on programmed cell death, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Intersectin scaffold proteins and their role in cell signaling and endocytosis.Biochimica et biophysica acta. Molecular cell research · 2017
    Review
  10. Article
  11. Article
  12. siRNA delivery to the lung: what's new?Advanced drug delivery reviews · 2014
    Review
  13. Review
  14. Article
  15. Article
  16. New insights into the functions of intersectin-1s.Communicative & integrative biology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Cristina BarditaDepartment of Pharmacology, Rush University, 1735 W. Harrison St., Chicago, IL 60612, USA.
Dan Predescu
Matthew J Justice
Irina Petrache
Sanda Predescu
Rush University · USIndiana University – Purdue University Indianapolis · US

Funding

Intersectin-1s regulates lung vascular permeability and endothelial cell survivalR01HL089462 · NHLBI · RUSH UNIVERSITY MEDICAL CENTER · PI PREDESCU, SANDA A · 2008 to 2012
$2.1M
Direct and Bone-Marrow Mediated Effects of Adipose Stem Cells in EmphysemaR01HL105772 · NHLBI · NATIONAL JEWISH HEALTH · PI MARCH, KEITH LEONARD, PETRACHE, IRINA · 2012 to 2015
$1.5M
NHLBI NIH HHS R01 HL089462NHLBI NIH HHS R01HL089462NHLBI NIH HHS R01HL089462-02S1NHLBI NIH HHS R01 HL105772
6 · The paper itself

Abstract

Intersectin-1s (ITSN-1s) is a general endocytic protein involved in regulating lung vascular permeability and endothelial cells (ECs) survival, via MEK/Erk1/2(MAPK) signaling. To investigate the in vivo effects of ITSN-1s deficiency and the resulting ECs apoptosis on pulmonary vasculature and lung homeostasis, we used an ITSN-1s knocked-down (KD(ITSN)) mouse generated by repeated delivery of a specific siRNA targeting ITSN-1 gene (siRNA(ITSN)). Biochemical and histological analyses as well as electron microscopy (EM) revealed that acute KD(ITSN) [3-days (3d) post-siRNA(ITSN) treatment] inhibited Erk1/2(MAPK) pro-survival signaling, causing significant ECs apoptosis and lung injury; at 10d of KD(ITSN), caspase-3 activation was at peak, terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL)-positive ECs showed 3.4-fold increase, the mean linear intercept (MLI) showed 48 % augment and pulmonary microvessel density as revealed by aquaporin-1 staining (AQP-1) decreased by 30 %, all compared to controls; pulmonary function was altered. Concomitantly, expression of several growth factors known to activate Erk1/2(MAPK) and suppress Bad pro-apoptotic activity increased. KD(ITSN) altered Smads activity, downstream of the transforming growth factor beta-receptor-1 (TβR1), as shown by subcellular fractionation and immunoblot analyses. Moreover, 24d post-siRNA(ITSN), surviving ECs became hyper-proliferative and apoptotic-resistant against ITSN-1s deficiency, as demonstrated by EM imaging, 5-bromo-deoxyuridine (BrdU) incorporation and Bad-Ser(112/155) phosphorylation, respectively, leading to increased microvessel density and repair of the injured lungs, as well as matrix deposition. In sum, ECs endocytic dysfunction and apoptotic death caused by KD(ITSN) contribute to the initial lung injury and microvascular loss, followed by endothelial phenotypic changes and microvascular remodeling in the remaining murine pulmonary microvascular bed.

Indexed as

Adaptor Proteins, Vesicular TransportAnimalsApoptosisCapillary PermeabilityEndothelial CellsGene Knockdown TechniquesLungLung InjuryMicePhenotypeAdaptor Proteins, Vesicular Transportintersectin 1

Identifiers

PMID23054079
PMCPMC3543613
OpenAlexW2042381635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.